Entertainment
Education
Health
AI Progress in Healthcare: How Intelligent Technology Is Transforming Patient Care
Mumbai (Maharashtra) [India], July 7: AI isn’t just a futuristic idea anymore—it’s here, woven into daily life whether you notice it or not. Netflix lines up your next show, Siri chimes in with the weather, and honestly, nowhere is AI making a bigger impact than in healthcare. It’s not the showy kind of change, but behind the curtain, AI helps doctors, nurses, hospitals, and researchers tackle some of the toughest problems in medicine. It’s changing patient care without the fanfare.
Sure, medicine has always been built on people—skill, experience, genuine care. But these days, everything’s busier: more patients, growing expenses, a chronic shortage of staff. It’s a tough balancing act. That’s where AI steps in. It’s not here to boot doctors aside. Think of it as a really sharp assistant: fast with facts, strong on predictions, and happy to handle the boring stuff.
Let’s talk about diagnosing illnesses. Not so long ago, you needed stacks of tests and specialist opinions to get a clear answer. AI-powered tools can now sift through X-rays or MRIs in seconds, sometimes catching the tiny details most of us would miss. Things like cancer, pneumonia, or heart trouble get picked up much sooner—which can make all the difference when it comes to beating them.
Doctors also face a tidal wave of data every day—lab results, notes, prescriptions, reports. There’s no way to sort it all out by hand anymore. That’s where AI jumps in, scanning records, spotting patterns, flagging anything weird or worrying. But make no mistake, the doctor makes the final call. AI just lines up the best info, so decisions get sharper and faster.
Then there’s personalized medicine. No two people are identical, so why give everyone the same treatment? AI zooms out and considers your genes, habits, age, your medical story—the whole bag. It helps doctors handcraft plans that actually fit you, not just the “average” patient. That means meds and advice land better, and side effects don’t hit as hard.
And AI isn’t tucked away in some high-tech lab. Got a smartwatch? Use a health app? That’s AI, quietly watching out for you—tracking steps, sleep, heartbeats. Sometimes it catches warning signs before you even notice anything’s wrong. For folks dealing with diabetes or high blood pressure, smart alerts can head off emergencies and bring a little peace of mind.
Paperwork? Don’t even get started. Booking appointments, updating medical files, wrangling insurance—these chores eat up time that should go to patients. AI steps in, automating the boring, repetitive tasks so healthcare workers can spend more energy on actual care.
On the research front, AI keeps the engine humming. New medicine and treatments used to take years—plus a small mountain of cash. Now, AI sorts through massive data, spots the most promising drugs, and predicts what’s worth testing. See how COVID vaccines rolled out so quickly? AI played a big part in that speed.
Of course, AI isn’t a miracle fix. Healthcare runs on trust, and with all that patient data, privacy is crucial. Hospitals need to lock down information and use it right. If you feed AI bad or biased data, it can go off the rails in ways no one expects, which is serious business. Oversight matters. Good data, strong ethics—these aren’t optional.
Even with all the buzz, AI’s not about to sideline doctors and nurses. You can’t program compassion or comfort. Patients need real people for trust and understanding. AI’s great with data, but it doesn’t talk you through fear or pain.
AI in healthcare is still warming up. Pretty soon, you’ll see it spotting disease outbreaks before they explode, helping out in the OR, or checking in on patients at home. But here’s the thing: it’s not about robots for the sake of robots. The real win is people staying healthier, problems getting caught earlier, care that feels fairer, and medical pros finally getting to focus on what matters.
AI hasn’t hit its ceiling yet—it’s just starting out. The real breakthrough comes when people and smart machines work together. That’s when healthcare really leaps forward.
Business
Trom Industries Secures Multiple Rooftop Solar Orders Totalling 42 MW Under PM Surya Ghar Yojana
Gandhinagar (Gujarat) [India], July 11: Trom Industries Limited (NSE- TROM | INE0SYV01018) a solar EPC and clean energy solutions company, announced the receipt of three purchase orders from South Bihar Power Distribution Company Limited for the implementation of 42 MW of Grid-Connected Rooftop Solar Projects under the CAPEX plus RESCO Mode Utility-Led Aggregation (ULA) Model of the PM Surya Ghar – Muft Bijli Yojana (PMSG-MBY).
The projects collectively cover 38,561 consumer installations, each with a capacity of 1.1 KW, across the Aurangabad, Bhagalpur, and Biharsharif circles of South Bihar Power Distribution Company Limited (SBPDCL). The orders are scheduled to be executed within nine months from the date of signing of the respective Power Purchase Agreements (PPAs).
Order Details
- Biharsharif Circle: 17 MW covering 15,335 consumer installations
- Bhagalpur Circle: 15 MW covering 13,290 consumer installations
- Aurangabad Circle: 10 MW covering 9,936 consumer installations
These projects are being implemented under the Power Purchase Agreement (PPA) model, under which Trom Industries will receive recurring revenue from power generation over the tenure of the agreements. This long-term revenue stream is expected to strengthen the Company’s business model by improving revenue visibility, enhancing cash flow stability, and creating a sustainable annuity-based income alongside its EPC operations.
These orders further strengthen Trom Industries’ participation in large-scale government-backed rooftop solar programmes and reinforce its execution capabilities in the utility-led residential solar segment. The projects are aligned with the Government of India’s vision of accelerating distributed renewable energy adoption through the PM Surya Ghar – Muft Bijli Yojana.
Commenting on the order momentum, Mr. Jignesh Patel, Managing Director of Trom Industries Limited, said: “These orders represent an important milestone in our participation in India’s rapidly expanding rooftop solar ecosystem. The PM Surya Ghar initiative is creating significant opportunities for experienced EPC players, and we are pleased to contribute to this national programme. Our focus remains on timely execution, maintaining high quality standards, and strengthening our presence across government-led renewable energy projects”
About Trom Industries Limited
Trom Industries Limited (“was formerly known as Trom Solar”), incorporated in 2011, is an engineering, procurement, and construction (EPC) company specializing in solar energy solutions. Headquartered in Gujarat, the company focuses on residential and industrial solar power plants, Ground-mounted systems, and solar street lighting, with a strong presence across Gujarat and Maharashtra.
The Company serves a diverse portfolio of marquee clients, including RBI, ONGC, GAIL, Honda, Toyota, Vedanta, Amul, Corona Remedies Limited, Ahmedabad Municipal Corporation, ArcelorMittal Nippon Steel India Private Limited, GEDA, Apollo Infratech Private Limited, Royal Castor Products Limited, Vasant Masala Private Limited, and Sahajanand Laser Technology Limited. Trom Industries’ project portfolio spans government tenders, residential installations, and large-scale industrial and commercial solar projects. Committed to advancing sustainable energy adoption, Trom Industries offers customized renewable energy solutions such as solar rooftop systems, ground-mounted solar projects, solar street lighting, off-grid solutions, solar water purifiers, and solar pumps.
With over 100 MW of high-efficiency modules installed, 70 MW of experienced EPC execution, 45 MW of complete operation and maintenance services, and more than 30,000 satisfied customers. Trom Indus leverages technical expertise and local market knowledge to deliver reliable and cost-effective renewable energy solutions.
In FY26, the company reported consolidated total income of ₹125 Cr, with an EBITDA of ₹12 Cr and net profit of ₹7 Cr
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.
